Sjogren's syndrome in association with Crohn's disease

Journal of Clinical Gastroenterology

Volumn 37, Issue 4, 2003, Pages 312-314

  Rhew, Elisa Y ^a   Ramsey Goldman, Rosalind ^a   Buchman, Alan L ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Crohn's disease; Sjogren's syndrome

Indexed keywords

BUDESONIDE; DNA ANTIBODY; DOUBLE STRANDED DNA; HYDROCHLOROTHIAZIDE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN M; IODINATED CONTRAST MEDIUM; PENICILLIN DERIVATIVE; PILOCARPINE; PROTEIN; SULFANILAMIDE DERIVATIVE;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; COLONOSCOPY; CROHN DISEASE; DISEASE ASSOCIATION; DROWSINESS; DRUG HYPERSENSITIVITY; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; HUMAN; INTESTINE BIOPSY; INTESTINE RADIOGRAPHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS; SJOEGREN SYNDROME; XEROSTOMIA;

CROHN DISEASE; FEMALE; HUMANS; MIDDLE AGED; SJOGREN'S SYNDROME;

EID: 0141608921     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200310000-00010     Document Type: Article

References (26)

1. Moutsopoulos HM, Webber BL, Vlagopoulos TP, et al. Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med. 1979;66:733-736.
2. Godaert GL, Hartkamp A, Geenen R, et al. Fatigue in daily life in patients with primary Sjogren's's syndrome and systemic lupus erythematosus. Ann NY Acad Sci. 2002;966:320-326.
3. Nishimori I, Masanori M, Kino J, et al. Pancreatic involvement in patients with Sjogren's's syndrome and primary biliary cirrhosis. Int J Pancreatol. 1995;17:47-54.
4. Tsianos EB, Vasakos S, Drosos AA, et al. The gastrointestinal involvement in primary Sjogren's's syndrome. Scand J Rheumatol. 1986;61 (suppl):151-155.
5. Pal B, Griffiths ID, Katrak A, et al. Salivary amylase and pancreatic enzymes in Sjogren's's syndrome. Clin Chem. 1987;33:305-307.
6. Williamson J, Cant JS, Mason DK, et al. Sjogren's's syndrome and thyroid disease. Br J Ophthalmol. 1967;51:721-726.
7. Coll J, Anglada J, Tomas S, et al. High prevalence of subclinical Sjogren's's syndrome features in patients with autoimmune thyroid disease. J Rheumatol. 1997;24:1719-1724.
8. Perez-E B, Kraus A, Lopez G, et al. Autoimmune thyroid disease in primary Sjogren's's syndrome. Am J Med. 1995;99:480-484.
9. Palm Oyvind P, Moum B, Gran JT. Estimation of Sjogren's's syndrome among IBD patients. Scand J Rheumatol. 2002;31:140-145.
10. Triantafillidis JK, Roussou P, Manousos ON, et al. Ulcerative colitis and Sjogren's's syndrome in the same patient: report of two cases and a review of the literature. Ital J Gastroenterol. 1994;26:299-302.
11. Cox NH, McCrea JD. A case of Sjogren's's syndrome, sarcoidosis, previous ulcerative colitis and gastric autoantibodies. Br J Dermatol. 1996;134:1138-1140.
12. Steuer A, McCrea DJ, Colaco CB. Primary Sjogren's's syndrome, ulcerative colitis and selective IgA deficiency. Postgrad Med J. 1996;72:499-500.
13. Fujimori J, Yoshino S, Morishige Y, et al. A case ofrheumatoid arthritis with systemic lupus erythematosus, Sjogren's's syndrome and Crohn's disease. Ryumachi. 1987;27:294-300.
14. Gainy R, Rooney PJ, Alspaugh M. Sjogren's's syndrome and Crohn's disease. Clin Exp Rheumatol. 1985;3:67-69.
15. Carneros JA. Crohn's disease in a patient with Hashimotos thyroiditis and Sjogren's's syndrome. Med Clin (Barc). 2002;119:78-79.
16. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology. 1994;106:533-539.
17. Valdez IH, Fox PC. Interactions of the salivary and gastrointestinal systems. Dig Dis. 1991;9:210-218.
18. Maury CPJ, Tomroth I, Teppo A-M. Atrophic gastritis in Sjogren's's syndrome: morphologic, biochemical and immunologic findings. Arthritis Rheum. 1985;48:388-394.
19. Skopouli FN, Barbatis C, Moustopoulos HM. Liver involvement in primary Sjogren's's syndrome. Br J Rheumatol. 1994;33:745-748.
20. Anaya J, Talal N. Sjogren's's syndrome comes of age. Semin Arthritis Rheum. 1999;28:355-359.
21. Feldman M, Friedman LS, Sleisenger MH. Sleisenger & Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management, 7th ed. Philadelphia: W.B. Saunders; 2002:2005-2009.
22. Fotini N, Skopouli FN, Fox PC, et al. T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjogren's's syndrome. J Rheumatol. 1991;18:210-214.
23. Breese E, Braegger CP, Corrigan CJ, et al. Interleukin-2 and interferon-gamma-secreting T cells in normal and diseased human intestinal mucosa. Immunology. 1993;78:127-131.
24. Mullin GE, Lazenby AJ, Harris ML, et al. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology. 1992;102:1620-1627.
25. Sun D, Emmert-Buck MR, Fox PC. Differential cytokine mRNA expression in human labial minor salivary glands in primary Sjogren's's syndrome. Autoimmunity. 1998;28:125.
26. Powrie F, Leach MW, Mauze S, et al. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ cells. Immunity. 1994;1:553-562.